Listed

TherapeuticsMD, Inc.: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Feb 26, 2016 and accepted by EDGAR at Feb 26, 2016, 16:33 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-10-01 to 2015-12-31$5.6mus-gaap:SalesRevenueNet
Revenue12 months2015-01-01 to 2015-12-31$20.1mus-gaap:SalesRevenueNet
Cost of revenue12 months2015-01-01 to 2015-12-31$4.5mus-gaap:CostOfGoodsSold
Gross profit3 months2015-10-01 to 2015-12-31$4.4mus-gaap:GrossProfit
Gross profit12 months2015-01-01 to 2015-12-31$15.6mus-gaap:GrossProfit
Research and development12 months2015-01-01 to 2015-12-31$72.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2015-01-01 to 2015-12-31$28.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2015-01-01 to 2015-12-31−$85.2mus-gaap:OperatingIncomeLoss
Net income3 months2015-10-01 to 2015-12-31−$17.8mus-gaap:NetIncomeLoss
Net income12 months2015-01-01 to 2015-12-31−$85.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-10-01 to 2015-12-31−$0.10us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2015-01-01 to 2015-12-31−$0.49us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2015-01-01 to 2015-12-31−$79.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2015-01-01 to 2015-12-31$165.3kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-12-31$64.7mus-gaap:Cash
Current assetsAt period end2015-12-31$70.7mus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$73.7mus-gaap:Assets
Current liabilitiesAt period end2015-12-31$10.7mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2015-12-31$63.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001387131-16-004361. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.